Bio

Teaching

Full contribution to teaching in Dundee, especially cardiology and clinical pharmacology. Member of Undergraduate Medical School Assessment Committee. External undergraduate examinerships (National University of Singapore, University of Malaya, International Medical University, Malaysia, National University of Malaysia). Supervisor of 25 MD/PhDs personally. External examiner for MD (Universities of Birmingham, Cardiff, Edinburgh, Glasgow)

Biography

Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at Ninewells Hospital and Medical School, Dundee, United Kingdom. He trained in both cardiology and clinical pharmacology in the United Kingdom and in the United States where he was a Merck International Fellow in Clinical Pharmacology at Vanderbilt University, Nashville and a Fulbright Scholar at Columbia University, New York. He is a Fellow of the Royal Colleges of Physicians of London and Edinburgh and the American College of Cardiology.

Research

His research takes a multi-disciplinary approach to the understanding of the pathophysiology and pharmacogenetics of cardiovascular diseases and to the development of treatment strategies in patients with cardiovascular diseases. He leads an integrated cardiovascular research laboratory dedicated and equipped to the study of cardiac and vasomotor regulation. These techniques are applied towards translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. Prof Lang is the Work Package Lead for the validation cohort for the FP-7 funded BIOSTAT-CHF study that aims optimize the treatment of heart failure for each individual using information from genomics and proteomics. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, Chest Heart and Stroke Scotland, Tenovus and the European commission Seventh Framework Programme (FP-7) funds his research.

'Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF'European Journal of Heart Failure.https://doi.org/10.1002/ejhf.1079

'Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes'European Journal of Cardiovascular Nursing, vol. 13, no. 3, pp. 253-260. https://doi.org/10.1177/1474515113488026

'High-Dose Allopurinol reduces left ventricular mass in patients with ischemic heart disease'Journal of the American College of Cardiology, vol. 61, no. 9, pp. 926-32. https://doi.org/10.1016/j.jacc.2012.09.066

'Allopurinol reduces left ventricular mass in patients with type ii diabetes and left ventricular hypertrophy'Journal of the American College of Cardiology, vol. 61, no. 10 Supplement, pp. E1256. https://doi.org/10.1016/S0735-1097(13)61256-5

'Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease'Journal of the American College of Cardiology, vol. 60, no. 11, pp. 960-968. https://doi.org/10.1016/j.jacc.2012.04.049

'The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study'Journal of the American College of Cardiology, vol. 58, no. 20, pp. 2084-2091. https://doi.org/10.1016/j.jacc.2011.07.043